Top Markets
Coin of the day
Inventiva S.A. Inventiva S.A.

Inventiva S.A.

IVA
Classement en actions #8990
Inventiva S.A. is a biopharmaceutical firm currently in the clinical... Inventiva S.A. is a biopharmaceutical firm currently in the clinical development phase, specializing in creating orally administered small molecule treatments for conditions such as non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and various other ailments. Their primary drug candidate, Lanifibranor, has successfully concluded Phase IIb clinical trials for the management of NASH. Furthermore, the company is advancing Odiparcil, a compound that has finished Phase IIa clinical testing specifically for treating the MPS VI subtype. Beyond these, Inventiva maintains a development pipeline featuring several early-stage projects targeting oncology and other medical conditions. Strategic partnerships are in place with AbbVie to address autoimmune diseases, and with Boehringer Ingelheim International GmbH for innovating therapies for idiopathic pulmonary fibrosis. Established in 2011, Inventiva S.A. operates from its headquarters in Daix, France.
Prix de l'action
$4.74
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$1.12B
Changement (1 jour)
-5.77%
Changement (1 an)
-16.96%
Pays
FR
Échange Inventiva S.A. (IVA)

Catégorie

Historique des divisions d’actions pour Inventiva S.A. (IVA)
L’action Inventiva S.A. (symbole : IVA) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 29, 2026.
Une action IVA achetée avant le Aug 29, 2026 équivaudrait aujourd’hui à 0 actions IVA.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH